View Older Stories View More Recent Stories

Feb 6, 2015 10:08AM Roth Cuts PT on Synta Pharma (SNTA) to $20; Still Attractively Priced Given Ganetespib Potential

Feb 6, 2015 08:46AM Ohr Pharmaceutical (OHRP) Prices 3.7M Common Offering at $6.75/Share

Feb 6, 2015 06:43AM Roth Capital Resukmes Acadia Pharmaceuticals (ACAD) at Buy

Feb 4, 2015 09:17AM Roth Positive on Can-Fite Bio Pharma (CANF) Following Completion of CF101 Phase 2/3

Feb 4, 2015 09:04AM Catyalyst Pharmaceutical (CPRX) Prices 10M Shares at $3.25/Share

Feb 4, 2015 08:15AM Tonix Pharmaceuticals (TNXP) Prices 4.9M Common Offering at $5.85/Share

Feb 3, 2015 04:04PM Tonix Pharmaceuticals (TNXP) Plans Common Stock Offering

Feb 3, 2015 04:04PM Tonix Pharmaceuticals (TNXP) to Offer Common Stock

Feb 3, 2015 12:20PM Streetinsider.com's Hot Lunchtime Reads 2/3: (SLXP) (MMM) (TRP) (AAPL) (FNMA)

Feb 3, 2015 11:52AM Canadian Solar (CSIQ) Acquisition of Recurrent Energy Should Boost N. American Pipeline - Roth Capital

Feb 3, 2015 10:18AM Ligand's (LGND) License with Sermonix Demonstrates Great Example of Core Business Model - Roth Capital

Feb 2, 2015 02:43PM Roth Capital Positive on BioBlast Pharma (ORPN) CEO Appointment; Affirms at 'Buy'

Feb 2, 2015 10:20AM Notable Analyst Rating Changes 2/2: (DMND) (CPLP) (DECK) Upgraded; (GES) (GHL) (ARR) Downgraded

Feb 2, 2015 09:45AM UPDATE: Roth Capital Starts Hannon Armstrong (HASI) at Buy

Feb 2, 2015 07:39AM Roth Capital Upgrades Quiksilver (ZQK) to Buy

Jan 29, 2015 12:14PM Streetinsider.com's Hot Lunchtime Reads 1/29: (AAPL) (PCYC) (AERI) (AMZN)

Jan 29, 2015 11:50AM Roth Capital Bumps PT on Pharmacyclics (PCYC) to $189 Following Expanded IMBRUVICA Indication

Jan 29, 2015 10:27AM Flex Pharm (FLKS) IPO Opens Up 19%

Jan 28, 2015 08:33AM Synergy Resources (SYRG) Prices 16.2M Share Offering at $10.75/Share

Jan 28, 2015 07:57AM Roth Remains Positive on Ligand (LGND) Following Kyprolis Q4 Sales Data, sNDA Filing (AMGN)

Jan 27, 2015 10:32AM Zosano Pharma (ZSAN) IPO Opens Higher

Jan 27, 2015 08:26AM Zosano Pharma (ZSAN) Prices 4.5M Common IPO at $11/Share

Jan 27, 2015 08:24AM Zosano Pharma Announces Pricing of Initial Public Offering

Jan 26, 2015 09:41AM Regeneron (REGN), Sanofi (SNY) on 'Last Stretch' of Praluent Development - Roth Capital

Jan 23, 2015 01:52PM Roth Capital Trims Verastem (VSTM) PT to $23 Followng Financing Activity

Jan 23, 2015 09:52AM Roth Capital Downgrades Uroplasty (UPI) to Neutral

Jan 22, 2015 06:41AM Keryx Biopharma (KERX) Prices 9.17M Common Offering at $12/Share

Jan 21, 2015 07:53PM Keryx Biopharmaceuticals, Inc. Announces Pricing of $110 Million Public Offering of Common Stock

Jan 21, 2015 02:30PM Roth Affirms Curis (CRIS) at 'Buy' Following Aurigene Deal; Cuts PT to $6 on Dilution

Jan 20, 2015 09:24AM Roth Capital Affirms Verastem (VSTM) at 'Buy'; VS-6063, VS-5584 Combo Study Initiated

Jan 16, 2015 01:55PM Peregrine Pharma (PPHM) Starts 2015 Right with Strong Bavituximab in HCC Data - Roth Capital

Jan 16, 2015 01:09PM Unusual 11 Mid-Day Movers 1/16: (ASPS) (CRRC) (EOPN) Higher; (KONE) (NES) (PCP) Lower

Jan 16, 2015 12:21PM Streetinsider.com's Hot Lunchtime Reads 1/16: (CYTX) (FB) (AAPL) (C) (INTC)

Jan 16, 2015 12:15PM Roth Capital Nearly Doubles PT on Cytori (CYTX) to $6; Positive on Phase III STAR for Scleroderma

Jan 16, 2015 08:11AM Roth Capital Upgrades DepoMed Inc (DEPO) to Buy

Jan 15, 2015 08:24AM Roth Capital Downgrades Nuverra Environmental Solutions (NES) to Neutral

Jan 14, 2015 04:20PM Readout of PRESENTATION I Remains Major Catalyst for BioLineRx (BLRX) in FY15 - Roth Capital

Jan 14, 2015 07:52AM Roth Remains Positive on Pharmacyclics (PCYC) Following Imbruvica Update; Maintains 'Buy' Rating

Jan 13, 2015 06:17AM Lilis Energy (LLEX) Enters $50M Secured Facility

Jan 13, 2015 06:00AM Lilis Energy Secures Credit Facility With Heartland Bank for Up to $50 Million

Jan 12, 2015 07:19AM Roth Capital Downgrades Capstone Turbine (CPST) to Neutral

Jan 9, 2015 09:24AM Verastem's (VSTM) Progress in COMMAND, Other Clinical Programs is 'Impressive' - Roth Capital

Jan 9, 2015 07:25AM 2015 Could be 'Potentially Transformative' Year for GenVec (GNVC); Roth Affirms at 'Buy'

Jan 8, 2015 01:03PM Roth Adjusts Ests on Galena (GALE) Following FY15 Net Revs Outlook; 2015 Will be 'Busy Year' for Company

Jan 8, 2015 09:06AM Stemline Therapeutics (STML) Prices 3.8M Common Offering at $15.75/Share

Jan 8, 2015 09:05AM Stemline Therapeutics Prices $59.85 Million Public Offering of Common Stock

Jan 7, 2015 01:30PM PlacementTracker Publishes 2014 PIPE Market League Tables

Jan 7, 2015 06:57AM Roth Capital Starts Cempra, Inc. (CEMP) at Buy

Jan 6, 2015 02:21PM BioLineRx (BLRX) Continues Executing Well on BL-8040; Roth Capital Affirms at 'Buy'

Jan 6, 2015 01:09PM Unusual 11 Mid-Day Movers 1/6: (MOC) (TNXP) (FRO) Higher; (HGG) (CHOP) (CLDN) Lower

View More Recent Stories View Older Stories